G3 Group (GGL) operates three businesses: document and data management in New Zealand and Australia, a unique UK-based tourist souvenir business and a business mail operation in NZ. The performance for the three months to 31 December 2016 was strong, with both gross and operating margins reported ahead of target. The company attributes its outperformance to strong revenues in the higher-margin document management business versus the less profitable business mail unit. As expected, inventory days showed an increase due to the previously announced one-off buy up of business mail products during Q1. These will continue to reduce as the product is sold off. Management expects to achieve all key operating metrics (KOMs) in FY17e.
Companies: G3 GROUP
G3 Group (GGL) operates three businesses: document and data management in NZ and Australia, a unique UK-based tourist souvenir business and a business mail operation in NZ. The audited FY16 financial results showed NPAT of NZ$2.14m, which was 12.2% ahead of FY15 and included a PBT contribution of NZ$0.04m from Formfile Records Management Group, acquired on 20 January 2016. It also included costs associated with IPO and the introduction of an employee share scheme, totalling NZ$0.227m and NZ$0.345m, respectively. The key operating milestones (KOMs) performance for Q117 is below expectations for FY17 due to the short-term impact of a postage price increase and seasonal softness in the UK market.
G3 Group (GGL) operates three businesses: document and data management in NZ and Australia, a unique UK-based tourist souvenir business and a business mail operation in NZ. The audited FY16 financial results showed NPAT of NZ$2.14m, which was 12.2% ahead of FY15 and included a PBT contribution of NZ$0.040m from Formfile Records Management Group, acquired on 20 January 2016, as well as costs associated with IPO and introduction of an employee share scheme totalling NZ0.227m and NZ$0.345m respectively.
G3 Group operates three businesses: a New Zealand-based business mail operation, a unique UK tourist mail business (Universal Mail UK) and document management in New Zealand and Australia. The performance for the third quarter that ended 31 December 2015 showed gross margin and inventory levels for the quarter and year to date above the key operating milestone (KOM) targets. The volume of items processed in the third quarter was below the KOM target, but is expected to increase in the fourth quarter with the resumption of services to a major bulk customer.
G3 Group (GGL) operates three businesses: document and data management in New Zealand and Australia, a unique UK-based tourist souvenir business and a business mail operation in NZ. The performance for the six months ending 30 September 2016 showed a significant improvement versus the same period a year earlier, with underlying EBITDA growing by 24.9%. Strong growth in a G3 core home market of New Zealand post was one of the main drivers behind its strong performance. Furthermore, several bolt-on acquisitions continue to perform well, with the company announcing that it plans to continue looking for acquisition targets in its key markets.
G3 Group operates three businesses: a New Zealand-based business mail operation, a unique UK tourist mail business (Universal Mail UK) and document management in New Zealand. Following its successful listing on the NXT in June 2015, the company has provided the market with a business update for Q116 stating that all key operating milestones (KOMs) the company on track to meet its second quarter targets and KOMs.
G3 Group operates three businesses: a New Zealand-based business mail operation; a unique UK tourist mail business (Universal Mail UK); and document management in New Zealand. The compliance listing on the New Zealand NXT market does not include the raising of any capital and will provide a platform for organic and acquisition-fuelled growth.
Research Tree provides access to ongoing research coverage, media content and regulatory news on G3 GROUP.
We currently have 7 research reports from 1
Crimson Tide has reported a strong set of H1 results evidencing very strong sales momentum backed by long-term contracts and cash flow. H1 sales grew by 40% and EPS by 154%. Net cash has improved to £0.8m at June 2020 from nil at December 2019. The strategic focus on transportation and supermarkets is working well, partnerships are improving routes to market, and there is growing traction from investments in innovation. We have left our forecasts unchanged for now, but recognise positive pressure and have upgraded our target price from 3.1p to 4.3p. We reiterate our view that Crimson Tide’s valuation will be dictated by its ability to convert the significant opportunity rather than short-term metrics. H1 results show the group is nicely on track to do exactly that.
Companies: Crimson Tide Plc
Renalytix has officially commercially launched the KidneyIntelX testing platform with its launch partner Mount Sinai. The test is now fully integrated into the Mount Sinai health system, and goes beyond mere patient testing into a holistic approach to CKD patient support with Mount Sinai’s care delivery, physician education and support and billing pathways. This is a pivotal milestone for Renalytix triggering first commercial testing revenues, and was achieved in less than two years since Renalytix first IPOd in November 2018. It is estimated there are approx. 66,000 Diabetic kidney disease patients at the Mount Sinai health system, representing a significant initial addressable market opportunity. We continue to expect the launch and similar integrations of the KidneyIntelX platform into two further health care systems in FY’21. Simultaneously, Renalytix also announced agreements with LabCorp and an unnamed national medical logistics provider to use additional service centres to support the launch with the collection of blood samples at centres close to home or by primary physicians within the Mount Sinai system. Given the ongoing Covid-19 pandemic and the impact on physician visits, we believe this is beneficial and aids the use of KidneyIntelX to remotely monitor patients. This also provides a logistics framework to scale this process across multiple territories in the US.
Companies: Renalytix AI Plc
Cloud computing and connectivity provider for financial markets, Beeks Financial Cloud Group (“Beeks”), has reported FY 20A results in line with our forecasts. In our view the impressive growth in revenue and EBITDA delivered demonstrates the group’s defensive qualities against the COVID19 environment. The group also made strong operational progress during the year: FY 20A saw the strategically important (organic) Tier-1 client base reach five, alongside material expansion of the platform and a key new product launch. Management commentary on the outlook is positive, and we maintain our FY 21E earnings estimates following the announcement.
Companies: Beeks Financial Cloud Group Plc
The momentum in new orders and growth in recurring revenues seen in H1A, coupled with continued momentum into H2E, leads us to upgrade our recommendation to Buy. The macro backdrop for the utilisation of cloud services and the inherent risk to network security suggests the market for DDoS protection is only going in one direction.
Companies: Corero Network Security Plc
Ocado’s strong show in the retail business (+52% yoy) is likely to normalise in the coming quarters but the company is well placed to gain retail market share in the UK. The on-boarding of M&S has also been smooth to date and we expect the company to clock healthy sales growth in FY21 as the capacity constraints are likely to be eased. Despite being a healthy business, we continue to see Ocado as an overvalued business.
Companies: Ocado Group Plc
The headline numbers in this morning's results are not new news, having already been flagged to the market in the company's update on August 13th. Rather, the new news is (1) cost-savings in excess of £1m, (2) post-period end contract wins which add around £2m to FY20E likely revenues, (3) breaking of some H1 logjams due to Covid, with key design reviews passed for General Dynamics and substantial invoices raised and paid. £2m net cash on the balance sheet previously flagged is confirmed, and the Absolute Data Group (ADG) acquisition has integrated well. With effective conversion of the Letter of Intent relating to a Middle East customer during H1, and additional orders from other clients, the company's expectation of uplift in H2 looks to be well underpinned. Clearly the company rolled with the Covid punches in the first half; however the £1m annualised savings look to be really helpful in supporting FY21E financials and the order book remains healthy (+9% since the year end). Frustratingly, the Major Programme previously announced in PEN's pipeline remains a waiting game; however, we would still see conversion as transformational.
Companies: Pennant International Group Plc
LoopUp recently unveiled a major extension to its ambitions – the group is aiming to become a leading global provider of telephony “inside” Microsoft’s Teams product. The opportunity is clear and growing, as enterprise customers look to use Teams for “normal” external phone calls, and LoopUp seems well placed to deliver a differentiated offering using its existing infrastructure and knowhow. In this document we provide an overview of the new platform and explain its strategic significance.
Companies: LoopUp Group plc
Concurrent has delivered a strong H1/20 trading performance during a volatile period, with revenue of £9.2m (H1/19: £9.5m). Though COVID-19 caused initial uncertainty around FY20 activity levels, Concurrent is a supplier to some of the world's most prominent defence companies in the UK and US and was thus designated an essential defence supplier. Activity levels therefore continued throughout COVID-19 lockdown, with the defence market representing 68% (H1/19: 58%) of revenue in the period. Following strong order intake during H1/20 (record order book in May 2020) we have increased our revenue expectations by £1.7m to £18.7m for FY20. With £10m cash and no debt Concurrent is continuing to invest in R&D and progress its plans to add new hardware and software product ranges into new markets such as AI, software and services.
Companies: Concurrent Technologies Plc
Tern plc* (TERN.L, 8.0p/£24.1m) | Corero Network Security (CNS.L, 8.25p/£40.8m) | Eagle Eye Solutions Group plc (EYE.L, 288p/£86.9m)
Companies: TERN CNS EYE
Many of the world’s best and most important products (eg Space exploration, nuclear medicine/power & the internet) were originally invented by the military. It’s happened again – but this time to combat airborne pathogens like Ebola, SARS/MERS and all manner of other biological nasties doing the rounds. You see on 10th December 2018, Kromek was awarded a $2.0m contract by DARPA (research arm of US Dept. of Defense) to develop a vehicle-mounted bio-threat detector. The idea being that this should be able to rapidly identify (within 1 hour) any dangerous germ that might have been released into the environment, say by terrorist groups, organised criminals &/or rogue states.
Companies: Kromek Group Plc
Blackbird plc* (BIRD.L, 15.0p/£50.4m) | Brave Bison Group plc* (BBSN.L, 1.375p/£8.4m) | CML Microsystems plc (CML.L, 258p/£44.2m) | Eckoh plc (ECK.L, 61.5p/£156.2m)
Companies: BIRD BBSN CML ECK
CAP-XX Ltd* (CPX.L, 4.5p/£19.9m) | Gfinity plc* (GFIN.L, 3.8p/£28.9m) | MTI Wireless Edge Ltd* (MWE.L, 44p/£38.7m) | Newmark Security plc* (NWT.L, 1.175p/£5.5m)
Companies: CPX GFIN MWE NWT
We are introducing our Best Ideas for 2019 and also review the performance of last year’s picks. We suggest ten solidly financed stocks with good business dynamics that ought to be considered for core portfolio holdings and six UK domestically focused stocks that our analysts believe should perform strongly in the event that uncertainties unwind. We also introduce a new style of research from N+1 Singer which presents a Company’s dynamics and metrics in a clear and concise manner and concentrates on the pivotal issues affecting that Company and an investment decision.
Companies: BCA CLIN CLG CBP DNLM EAH STU FCRM FUTR GTLY INS GLE NICL SDL SPR TRI
Eckoh’s trading update today implies record FYMar20 results in line with market expectations. While not disclosed today, we estimate that the US saw u/l organic revenue growth of c. 18%, and within that, Secure Payments estimated growth of c. 70%, driving EPS growth of some 80% yoy. These results and today’s CV19 update are in line with our update from 31st March. Some delays have emerged in US SecPay decision-making, but deals should conclude in due course. As we flagged, the UK has seen some volume declines, but expect a rapid recovery when lockdown ends. Looking beyond short-term disruption, the stand-out opportunity for Eckoh is US SecPay. Here Eckoh has momentum and is market leader in a nascent market with a patent-protected solution. All that for an historic FCF yield of c. 5.5%.
Companies: Eckoh Plc
Customer orders in Q4E have moved to the right as a result of the COVID-19 crisis leading to a revenue shortfall in FY20E. While these orders are deferred and not cancelled, precise visibility over their future timing is limited and we are withdrawing forecasts for FY21E. Kromek's strong balance sheet adequately fully absorbs the shortfall in cash flow and we aim to reinstate forecasts by the time the company reports its final results.